Monoclonal Antibodies in Animal Biotechnology

 
Monoclonal antibodies
 
VBC-321
Animal Biotechnology
 
antibody
 
An 
antibody
 is a protein used by the immune system to identify
and neutralize foreign objects like bacteria and viruses. Each
antibody recognizes a specific antigen unique to its target.
 
 Monoclonal antibodies
 (
mAb
) are antibodies that are identical
because they were produced by one type of immune cell, all
clones of a single parent cell.
 
Polyclonal antibodies
 are antibodies that are derived from
different cell lines.
 
Isotypes
      
According to differences in their heavy chain constant
domains, immunoglobulins are grouped into five classes, or
isotypes: 
IgG
, 
IgA
, 
IgM
, 
IgD
, and 
IgE
.
 
Monoclonal Antibodies
 
Monoclonal antibodies
 (
mAb
) are 
antibodies
 that are
identical because they were produced by one type of
immune cell
, all 
clones
 of a single parent cell
Given (almost) any substance, it is possible to create
monoclonal antibodies that specifically bind to that
substance; they can then serve to detect or purify that
substance
This has become an important tool in 
biochemistry
,
molecular biology
 and 
medicine
 
The structure of antibodies
 
 
 
 
 
 
 
 
 
http://www.path.cam.ac.uk/~mrc7/igs/mikeimages.html
 
History of Mab development
 
1890 Von Behring and Kitasato discovered the serum of vaccinated persons
contained certain substances, termed antibodies
 
1900 Ehrlich proposed the “ side-chain theory”
 
1955 Jerne postulated natural selection theory. Frank Macfarlane Burnet
expended.
 
Almost the same time, Porter isolated fragment of antigen binding (Fab) and
fragment crystalline (Fc) from rabbit y-globulin.
 
1964 Littlefield developed a way to isolate hybrid cells from 2 parent cell lines
using the hypoxanthine-aminopterin-thymidine (HAT) selection media.
 
1975 Kohler and Milstein  provided the most outstanding proof of the clonal
selection theory by fusion of normal and malignant cells.  This resulted in the
first monoclonal antibodies, for which they received the Nobel Prize in 1984.
 
Hybridoma technology
It is technique of producing hybrid cell lines called
hybridomas
 by the fusion of fusing a specific
antibody-producing lymphocyte B cell
 
with a 
myeloma
cell 
that has an ability to grow in tissue culture
Hydridoma produce 
antibodies
 
produced that have 
single
specificity and
 are called 
monoclonal antibodies
.
This technique was discovered 
Georges Kohler 
of West
Germany, 
Cesal Milstein 
of Argentina and 
Niels Jerne 
of
Denmark in 1975.
They were awarded Nobel Prize for Physiology and
Medicine the 1984
 
Principal
 
This is based on fusion between myeoma cell (malignant plasma
cell) and spleen cell from suitable immunised animal.
Spleen can produce antibody but die in short period under culture
condition
Myeloma cell are adapted to grow permanently in cell culture
Myeloma cells cannot synthesize antibodies as they lack HGPRT
gene required for the synthesize the enzyme, hypoxanthine
guanine phosphoribosyl transferase (azaquinine resistant) or
thymidine kinase (bromodeoxy uridine resistant)
Mutant myeloma cell can not grow in HAT (Hypoxanthine
Aminopterin  Thymidine) medium
Only hybrid cell can grow in HAT medium and produce
monoclonal antibody
 
Method
1.
Immunization of a mouse
2.
Isolation of B cells from the spleen
3.
Cultivation of myeloma cells
4.
Fusion of myeloma and B cells
5.
Separation of cell lines
6.
Screening of suitable cell lines
7.
in vitro
 (a) or 
in vivo
 (b) multiplication
8.
Harvesting
Immunization of a mouse
Immunize a rabbit through repeated injection of a specific
antigen for the production of specific antibody, facilitated
due to proliferation of the desired B cells
Produce tumors in a mouse or a rabbit
Culture separately the spleen cells that produce specific
antibodies and the myeloma cells that produce tumors
 
Fusion
Fusion of spleen 
cells to myeloma cells is
induced  using 
polyethylene glycol (PEG), 
to
produce 
hybridoma
Hybridomas are grown in selective
hypoxanthine aminopterin thymidine (HAT)
medium.
HAT medium contains a 
drug,
 
aminopterin
that blocks one pathway for nucleotide
synthesis, making the cells dependent on
another pathway that needs HGPRT enzyme,
which is absent in myeloma cells.
Myeloma cells that do not fuse with B cells
will die.
B cells that do not fuse will also die because
they lack tumorigenic property of immortal
growth.
Select desired hybridoma for cloning and
antibody production
Prepare 
single cell colonies 
that can grow
and use them to screen of antibody
producing hybridomas
Only one in several hundred cell hybrids will
produce antibodies of the desired specificity
Culture selected hybridoma cells for the
production of monoclonal antibodies in large
quantities
Hybridoma cells can be 
frozen
 for future use
or can be 
injected
 in the body of an animal,
so that antibodies will be produced in the
body and recovered later from the body fluid.
 
Selection and Storage
Slide Note
Embed
Share

Monoclonal antibodies (mAb) play a crucial role in identifying and neutralizing foreign substances in the body. This article delves into the significance of monoclonal antibodies, their structure, development history, and the revolutionary hybridoma technology. Explore the world of antibodies and their impact on biochemistry, molecular biology, and medicine.

  • Monoclonal antibodies
  • Antibody technology
  • Hybridoma
  • Immune system
  • Biochemistry

Uploaded on Aug 03, 2024 | 1 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.

E N D

Presentation Transcript


  1. VBC-321 Animal Biotechnology Monoclonal antibodies ?

  2. antibody An antibody is a protein used by the immune system to identify and neutralize foreign objects like bacteria and viruses. Each antibody recognizes a specific antigen unique to its target. Monoclonal antibodies (mAb) are antibodies that are identical because they were produced by one type of immune cell, all clones of a single parent cell. Polyclonal antibodies are antibodies that are derived from different cell lines. Isotypes According to differences in their heavy chain constant domains, immunoglobulins are grouped into five classes, or isotypes: IgG, IgA, IgM, IgD, and IgE.

  3. Monoclonal Antibodies Monoclonal antibodies (mAb) are antibodies that are identical because they were produced by one type of immune cell, all clones of a single parent cell Given (almost) any substance, it is possible to create monoclonal antibodies that specifically bind to that substance; they can then serve to detect or purify that substance This has become an important tool in biochemistry, molecular biology and medicine

  4. The structure of antibodies http://www.path.cam.ac.uk/~mrc7/igs/mikeimages.html

  5. History of Mab development 1890 Von Behring and Kitasato discovered the serum of vaccinated persons contained certain substances, termed antibodies 1900 Ehrlich proposed the side-chain theory 1955 Jerne postulated natural selection theory. Frank Macfarlane Burnet expended. Almost the same time, Porter isolated fragment of antigen binding (Fab) and fragment crystalline (Fc) from rabbit y-globulin. 1964 Littlefield developed a way to isolate hybrid cells from 2 parent cell lines using the hypoxanthine-aminopterin-thymidine (HAT) selection media. 1975 Kohler and Milstein provided the most outstanding proof of the clonal selection theory by fusion of normal and malignant cells. This resulted in the first monoclonal antibodies, for which they received the Nobel Prize in 1984.

  6. Hybridoma technology It is technique of producing hybrid cell lines called hybridomas by the fusion of fusing a specific antibody-producing lymphocyte B cell with a myeloma cell that has an ability to grow in tissue culture Hydridoma produce antibodies produced that have single specificity and are called monoclonal antibodies. This technique was discovered Georges Kohler of West Germany, Cesal Milstein of Argentina and Niels Jerne of Denmark in 1975. They were awarded Nobel Prize for Physiology and Medicine the 1984

  7. Principal This is based on fusion between myeoma cell (malignant plasma cell) and spleen cell from suitable immunised animal. Spleen can produce antibody but die in short period under culture condition Myeloma cell are adapted to grow permanently in cell culture Myeloma cells cannot synthesize antibodies as they lack HGPRT gene required for the synthesize the enzyme, hypoxanthine guanine phosphoribosyl transferase (azaquinine resistant) or thymidine kinase (bromodeoxy uridine resistant) Mutant myeloma cell can not grow in HAT (Hypoxanthine Aminopterin Thymidine) medium Only hybrid cell can grow in HAT medium and produce monoclonal antibody

  8. Method Immunization of a mouse Isolation of B cells from the spleen Cultivation of myeloma cells Fusion of myeloma and B cells Separation of cell lines Screening of suitable cell lines in vitro (a) or in vivo (b) multiplication Harvesting 1. 2. 3. 4. 5. 6. 7. 8.

  9. Immunization of a mouse Immunize a rabbit through repeated injection of a specific antigen for the production of specific antibody, facilitated due to proliferation of the desired B cells Produce tumors in a mouse or a rabbit Culture separately the spleen cells that produce specific antibodies and the myeloma cells that produce tumors

  10. Fusion Fusion of spleen cells to myeloma cells is induced using polyethylene glycol (PEG), to produce hybridoma Hybridomas are grown in selective hypoxanthine aminopterin thymidine (HAT) medium. HAT medium contains a drug, aminopterin that blocks one pathway for nucleotide synthesis, making the cells dependent on another pathway that needs HGPRT enzyme, which is absent in myeloma cells. Myeloma cells that do not fuse with B cells will die. B cells that do not fuse will also die because they lack tumorigenic property of immortal growth.

  11. Selection and Storage Select desired hybridoma for cloning and antibody production Prepare single cell colonies that can grow and use them to screen of antibody producing hybridomas Only one in several hundred cell hybrids will produce antibodies of the desired specificity Culture selected hybridoma cells for the production of monoclonal antibodies in large quantities Hybridoma cells can be frozen for future use or can be injected in the body of an animal, so that antibodies will be produced in the body and recovered later from the body fluid.

Related


More Related Content

giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#